BP001552-PRO-287: Recombinant Human Carcinoembryonic Antigen (CEA) Protein
Source: E. coli-derived.
Purity: > 90.0% as determined by SDS-PAGE.BP001674-C448: Recombinant Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001695-C449: Recombinant Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 3 (CEACAM3) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001776-C583: Recombinant Human Carcinoembryonic Antigen-Related Cell Adhesion Molecule 8 (CEACAM8) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).C109P: Tusamitamab Biosimilar, CEACAM5 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The research grade tusamitamab biosimilar specifically binds to the CEACAM5 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by tusamitamab.